Aa
Aa
A
A
A
Close
6708370 tn?1471490210

Is 12 weeks of treatment enough?

Here's the latest from the AASLD Conference:

Official Conference Coverage of the 2015 Annual Meeting of the American Association for the Study of Liver Diseases

Capsule Summaries

David R. Nelson, MD
Norah Terrault, MD, MPH

Review the most important studies from The Liver Meeting 2015. Selected by experts David R. Nelson, MD, and Norah Terrault, MD, MPH, each Capsule Summary presents the key data and figures from a vital study presented at the meeting. The following Capsule Summaries are now available:

In partnership with

ASTRAL-1: 99% SVR Rate With 12 Weeks of Sofosbuvir/Velpatasvir in Treatment-Naive or Treatment-Experienced Patients With Genotype 1, 2, 4, 5, or 6 HCV Infection
High SVR rates maintained across patient subgroups, including cirrhotic and treatment-experienced patients; adverse event rates similar to placebo.
Read More

HCV-TARGET: 8-24 Weeks of Ledipasvir/Sofosbuvir Highly Effective Against Genotype 1 HCV in Real-World Settings
Analysis finds 8-week regimen is underused, despite being highly effective in qualifying patients.
Read More

High SVR Rates With 12-24 Weeks of Daclatasvir Plus Sofosbuvir With or Without RBV in Patients With Genotype 3 HCV and Advanced Liver Disease
Use of shorter 12-week treatment regimen highly effective in patients with F3 disease.
Read More

High SVR12 Rates With Ravidasvir Plus Sofosbuvir With or Without Ribavirin in Cirrhotic and Noncirrhotic Patients With Genotype 4 HCV Infection
No relapse in noncirrhotic patients regardless of inclusion of ribavirin; no relapse in cirrhotic patients with 16 weeks of treatment including ribavirin.
Read More

These Capsule Summaries are part of CCO's Official Conference Coverage: Clinical Impact of New Data From AASLD 2015. For more coverage, including forthcoming Capsule Summaries, please visit clinicaloptions.com/2015AASLD.

Coming soon: CME-certified Expert Analysis: leading experts discuss the clinical implications of new data from the meeting in San Francisco

If you want to read more, go to:

http://www.clinicaloptions.com/Hepatitis/Conference%20Coverage/AASLD%202015/Highlights/Capsules/LB2.aspx?lg=mobile

You have to create an account but it's easy and they will send you updates via email
2 Responses
Sort by: Helpful Oldest Newest
317787 tn?1473358451
Very good information, thanks so much for sharing :)
Helpful - 0
Avatar universal
"is 12 weeks enough?"
I hope so. I'm half way through 12 weeks of SOF+DAC without Riba. Geno 3, F3 Fibro test.
Failed interferon + Riba 8 years ago. I expressed concerns with my doc since I previously failed but he seemed confident that Riba or extension would not be needed.
Now I'm undetectable at 4 weeks.
Fingers crossed...
Helpful - 0
Have an Answer?

You are reading content posted in the Hepatitis C Community

Top Hepatitis Answerers
317787 tn?1473358451
DC
683231 tn?1467323017
Auburn, WA
Learn About Top Answerers
Didn't find the answer you were looking for?
Ask a question
Answer a few simple questions about your Hep C treatment journey.

Those who qualify may receive up to $100 for their time.
Explore More In Our Hep C Learning Center
image description
Learn about this treatable virus.
image description
Getting tested for this viral infection.
image description
3 key steps to getting on treatment.
image description
4 steps to getting on therapy.
image description
What you need to know about Hep C drugs.
image description
How the drugs might affect you.
image description
These tips may up your chances of a cure.
Popular Resources
Herpes sores blister, then burst, scab and heal.
Herpes spreads by oral, vaginal and anal sex.
STIs are the most common cause of genital sores.
Condoms are the most effective way to prevent HIV and STDs.
PrEP is used by people with high risk to prevent HIV infection.
Can I get HIV from surfaces, like toilet seats?